Dataset Information


Distinct roles for basal and induced COX-2 in podocyte injury.

ABSTRACT: Transgenic mice that overexpress cyclooxygenase-2 (COX-2) selectively in podocytes are more susceptible to glomerular injury by adriamycin and puromycin (PAN). To investigate the potential roles of COX-2 metabolites, we studied mice with selective deletion of prostanoid receptors and generated conditionally immortalized podocyte lines from mice with either COX-2 deletion or overexpression. Podocytes that overexpressed COX-2 were virtually indistinguishable from wild-type podocytes but were significantly more sensitive to PAN-induced injury, produced more prostaglandin E(2) and thromboxane B(2), and had greater expression of prostaglandin E(2) receptor subtype 4 (EP(4)) and thromboxane receptor (TP). Treatment of COX-2-overexpressing podocytes with a TP antagonist reduced apoptosis, but treatment with an EP(4) antagonist did not. In contrast, podocytes from COX-2-knockout mice exhibited increased apoptosis, markedly decreased cell adhesion, and prominent stress fibers. In vivo, selective deletion of podocyte EP(4) did not alter the increased sensitivity to adriamycin-induced injury observed in mice overexpressing podocyte COX-2. In contrast, genetic deletion of TP in these mice prevented adriamycin-induced injury, with attenuated albuminuria and foot process effacement. These results suggest that basal COX-2 may be important for podocyte survival, but overexpression of podocyte COX-2 increases susceptibility to podocyte injury, which is mediated, in part, by activation of the thromboxane receptor.


PROVIDER: S-EPMC2736764 | BioStudies | 2009-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6063476 | BioStudies
1000-01-01 | S-EPMC6249220 | BioStudies
1000-01-01 | S-EPMC6251974 | BioStudies
2015-01-01 | S-EPMC4362257 | BioStudies
1000-01-01 | S-EPMC3900538 | BioStudies
1000-01-01 | S-EPMC5407711 | BioStudies
1000-01-01 | S-EPMC2736766 | BioStudies
2014-01-01 | S-EPMC4076473 | BioStudies
1000-01-01 | S-EPMC5749498 | BioStudies
2019-01-01 | S-EPMC6981397 | BioStudies